The interaction between HVEM and BTLA is lost in most follicular lymphomas
Loss of HVEM activates B cells and induces a supportive microenvironment
Soluble HVEM (solHVEM) restores the inhibitory BTLA signal and kills lymphoma cells
CAR-T cells that produce solHVEM (“micro-pharmacies”) are active against lymphoma